Utah 2025 Regular Session

Utah House Bill HB0500 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1		-	03-05 12:19 1st Sub. (Buff) H.B. 500
2		-	Kirk A. Cullimore proposes the following substitute bill:
	1	+	02-13 09:46 H.B. 500
3	2		1
4	3		Controlled Substance Modifications
5	4		2025 GENERAL SESSION
6	5		STATE OF UTAH
7	6		Chief Sponsor: Jennifer Dailey-Provost
8		-	Senate Sponsor: ~~Kirk A. Cullimore~~
	7	+	Senate Sponsor:
9	8		2
10	9
11	10		3
12	11		LONG TITLE
13	12		4
14	13		General Description:
15	14		5
16	15		This bill amends provisions related to the Controlled Substances Act.
17	16		6
18	17		Highlighted Provisions:
19	18		7
20	19		This bill:
21	20		8
22		-	▸ classifies amanita muscaria as a controlled substance~~; and~~
	21	+	▸ classifies amanita muscaria as a controlled substance.
23	22		9
24		-	~~▸ provides for the automatic rescheduling of a certain type of psilocybin if rescheduled by~~
	23	+	Money Appropriated in this Bill:
25	24		10
26		-	~~the federal government.~~
	25	+	None
27	26		11
28		-	~~Money Appropriated in this Bill~~:
	27	+	Other Special Clauses:
29	28		12
30	29		None
31	30		13
32		-	~~Other Special Clauses~~:
	31	+	Utah Code Sections Affected:
33	32		14
34		-	~~None~~
	33	+	AMENDS:
35	34		15
36		-	Utah ~~Code Sections Affected:~~
	35	+	58-37-4, as last amended by Laws of Utah 2024, Chapter 298
37	36		16
38		-	~~AMENDS:~~
	37	+
39	38		17
40		-	~~58-37-4, as last amended~~ by ~~Laws~~ of Utah ~~2024, Chapter 298~~
	39	+	Be it enacted by the Legislature of the state of Utah:
41	40		18
42		-
	41	+	Section 1. Section 58-37-4 is amended to read:
43	42		19
44		-	~~Be it enacted by the Legislature~~ of ~~the state of Utah:~~
	43	+	58-37-4 . Schedules of controlled substances -- Schedules I through V -- Findings
45	44		20
46		-	~~Section 1~~. ~~Section 58-37-4 is amended to read:~~
	45	+	required -- Specific substances included in schedules.
47	46		21
48		-	~~58-37-4 .~~ Schedules of controlled substances -- Schedules I ~~through V -- Findings~~
	47	+	(1) There are established five schedules of controlled substances known as Schedules I, II,
49	48		22
50		-	~~required --~~ ~~Specific~~ substances ~~included~~ in ~~schedules~~.
	49	+	III, IV, and V which consist of substances listed in this section.
51	50		23
52		-	(1) ~~There are established five schedules of controlled substances known as~~ Schedules I, II,
	51	+	(2) Schedules I, II, III, IV, and V consist of the following drugs or other substances by the
53	52		24
54		-	~~III~~, IV, ~~and V which consist of substances listed in this section.~~
	53	+	official name, common or usual name, chemical name, or brand name designated:
55	54		25
56		-	(2) ~~Schedules~~ I~~, II, III, IV, and V consist of the following drugs or other substances by the~~
	55	+	(a) Schedule I:
57	56		26
58		-	~~official name,~~ ~~common~~ or ~~usual name~~, ~~chemical name,~~ ~~or brand name designated:~~
	57	+	(i) Unless specifically excepted or unless listed in another schedule, any of the
59	58		27
60		-	~~(a) Schedule I:~~
	59	+	following opiates, including their isomers, esters, ethers, salts, and salts of
61	60		28
	61	+	isomers, esters, and ethers, when the existence of the isomers, esters, ethers, and
	62	+	29
	63	+	salts is possible within the specific chemical designation:
	64	+	30
	65	+	(A) Acetyl-alpha-methylfentanyl
	66	+	H.B. 500 H.B. 500 02-13 09:46
	67	+	31
	68	+	(N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
	69	+	32
	70	+	(B) Acetyl fentanyl: (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);
	71	+	33
	72	+	(C) Acetylmethadol;
	73	+	34
	74	+	(D) Acryl fentanyl (N-(1-Phenethylpiperidin-4-yl)-N-phenylacrylamide);
	75	+	35
	76	+	(E) Allylprodine;
	77	+	36
	78	+	(F) Alphacetylmethadol, except levo-alphacetylmethadol also known as
	79	+	37
	80	+	levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;
	81	+	38
	82	+	(G) Alphameprodine;
	83	+	39
	84	+	(H) Alphamethadol;
	85	+	40
	86	+	(I) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]
	87	+	41
	88	+	propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);
	89	+	42
	90	+	(J) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-
	91	+	43
	92	+	piperidinyl]-N-phenylpropanamide);
	93	+	44
	94	+	(K) Benzylpiperazine;
	95	+	45
	96	+	(L) Benzethidine;
	97	+	46
	98	+	(M) Betacetylmethadol;
	99	+	47
	100	+	(N) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-
	101	+	48
	102	+	piperidinyl]-N-phenylpropanamide);
	103	+	49
	104	+	(O) Beta-hydroxy-3-methylfentanyl, other name: N-[1-(2-hydroxy-2-
	105	+	50
	106	+	phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide;
	107	+	51
	108	+	(P) Betameprodine;
	109	+	52
	110	+	(Q) Betamethadol;
	111	+	53
	112	+	(R) Betaprodine;
	113	+	54
	114	+	(S) Butyryl fentanyl (N-(1-(2-phenylethyl)-4-piperidinyl)-N-phenylbutyramide);
	115	+	55
	116	+	(T) Clonitazene;
	117	+	56
	118	+	(U) Cyclopropyl fentanyl
	119	+	57
	120	+	(N-(1-Phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide);
	121	+	58
	122	+	(V) Dextromoramide;
	123	+	59
	124	+	(W) Diampromide;
	125	+	60
	126	+	(X) Diethylthiambutene;
	127	+	61
	128	+	(Y) Difenoxin;
	129	+	62
	130	+	(Z) Dimenoxadol;
	131	+	63
	132	+	(AA) Dimepheptanol;
	133	+	64
	134	+	(BB) Dimethylthiambutene;
	135	+	- 2 - 02-13 09:46 H.B. 500
	136	+	65
	137	+	(CC) Dioxaphetyl butyrate;
	138	+	66
	139	+	(DD) Dipipanone;
	140	+	67
	141	+	(EE) Ethylmethylthiambutene;
	142	+	68
	143	+	(FF) Etizolam
	144	+	69
	145	+	(1-Methyl-6-o-chlorophenyl-8-ethyl-4H-s-triazolo[3,4-c]thieno[2,3-e]1,4-diazepine);
	146	+	70
	147	+	(GG) Etonitazene;
	148	+	71
	149	+	(HH) Etoxeridine;
	150	+	72
	151	+	(II) Furanyl fentanyl (N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]
	152	+	73
	153	+	furan-2-carboxamide);
	154	+	74
	155	+	(JJ) Furethidine;
	156	+	75
	157	+	(KK) Hydroxypethidine;
	158	+	76
	159	+	(LL) Ketobemidone;
	160	+	77
	161	+	(MM) Levomoramide;
	162	+	78
	163	+	(NN) Levophenacylmorphan;
	164	+	79
	165	+	(OO) Methoxyacetyl fentanyl
	166	+	80
	167	+	(2-Methoxy-N-(1-phenylethylpiperidinyl-4-yl)-N-acetamide);
	168	+	81
	169	+	(PP) Morpheridine;
	170	+	82
	171	+	(QQ) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
	172	+	83
	173	+	(RR) Noracymethadol;
	174	+	84
	175	+	(SS) Norlevorphanol;
	176	+	85
	177	+	(TT) Normethadone;
	178	+	86
	179	+	(UU) Norpipanone;
	180	+	87
	181	+	(VV) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4- piperidinyl]
	182	+	88
	183	+	propanamide);
	184	+	89
	185	+	(WW) Para-fluoroisobutyryl fentanyl
	186	+	90
	187	+	(N-(4-Fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);
	188	+	91
	189	+	(XX) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
	190	+	92
	191	+	(YY) Phenadoxone;
	192	+	93
	193	+	(ZZ) Phenampromide;
	194	+	94
	195	+	(AAA) Phenomorphan;
	196	+	95
	197	+	(BBB) Phenoperidine;
	198	+	96
	199	+	(CCC) Piritramide;
	200	+	97
	201	+	(DDD) Proheptazine;
	202	+	98
	203	+	(EEE) Properidine;
	204	+	- 3 - H.B. 500 02-13 09:46
	205	+	99
	206	+	(FFF) Propiram;
	207	+	100
	208	+	(GGG) Racemoramide;
	209	+	101
	210	+	(HHH) Tetrahydrofuran fentanyl
	211	+	102
	212	+	(N-(1-Phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide);
	213	+	103
	214	+	(III) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]- propanamide;
	215	+	104
	216	+	(JJJ) Tilidine;
	217	+	105
	218	+	(KKK) Trimeperidine;
	219	+	106
	220	+	(LLL) 3-methylfentanyl, including the optical and geometric isomers
	221	+	107
	222	+	(N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N-phenylpropanamide);
	223	+	108
	224	+	(MMM) 3-methylthiofentanyl
	225	+	109
	226	+	(N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
	227	+	110
	228	+	(NNN) 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide also
	229	+	111
	230	+	known as U-47700; and
	231	+	112
	232	+	(OOO) 4-cyano CUMYL-BUTINACA.
	233	+	113
	234	+	(ii) Unless specifically excepted or unless listed in another schedule, any of the
	235	+	114
	236	+	following opium derivatives, their salts, isomers, and salts of isomers when the
	237	+	115
	238	+	existence of the salts, isomers, and salts of isomers is possible within the specific
	239	+	116
	240	+	chemical designation:
	241	+	117
	242	+	(A) Acetorphine;
	243	+	118
	244	+	(B) Acetyldihydrocodeine;
	245	+	119
	246	+	(C) Benzylmorphine;
	247	+	120
	248	+	(D) Codeine methylbromide;
	249	+	121
	250	+	(E) Codeine-N-Oxide;
	251	+	122
	252	+	(F) Cyprenorphine;
	253	+	123
	254	+	(G) Desomorphine;
	255	+	124
	256	+	(H) Dihydromorphine;
	257	+	125
	258	+	(I) Drotebanol;
	259	+	126
	260	+	(J) Etorphine (except hydrochloride salt);
	261	+	127
	262	+	(K) Heroin;
	263	+	128
	264	+	(L) Hydromorphinol;
	265	+	129
	266	+	(M) Methyldesorphine;
	267	+	130
	268	+	(N) Methylhydromorphine;
	269	+	131
	270	+	(O) Morphine methylbromide;
	271	+	132
	272	+	(P) Morphine methylsulfonate;
	273	+	- 4 - 02-13 09:46 H.B. 500
	274	+	133
	275	+	(Q) Morphine-N-Oxide;
	276	+	134
	277	+	(R) Myrophine;
	278	+	135
	279	+	(S) Nicocodeine;
	280	+	136
	281	+	(T) Nicomorphine;
	282	+	137
	283	+	(U) Normorphine;
	284	+	138
	285	+	(V) Pholcodine; and
	286	+	139
	287	+	(W) Thebacon.
	288	+	140
	289	+	(iii) Unless specifically excepted or unless listed in another schedule, any material,
	290	+	141
	291	+	compound, mixture, or preparation which contains any quantity of the following
	292	+	142
	293	+	hallucinogenic substances, or which contains any of their salts, isomers, and salts
	294	+	143
	295	+	of isomers when the existence of the salts, isomers, and salts of isomers is possible
	296	+	144
	297	+	within the specific chemical designation; as used in this Subsection (2)(a)(iii)
	298	+	145
	299	+	only, "isomer" includes the optical, position, and geometric isomers:
	300	+	146
	301	+	(A) Alpha-ethyltryptamine, some trade or other names: etryptamine; Monase; α
	302	+	147
	303	+	-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; α-ET; and AET;
	304	+	148
	305	+	(B) 4-bromo-2,5-dimethoxy-amphetamine, some trade or other names:
	306	+	149
	307	+	4-bromo-2,5-dimethoxy-α-methylphenethylamine; 4-bromo-2,5-DMA;
	308	+	150
	309	+	(C) 4-bromo-2,5-dimethoxyphenethylamine, some trade or other names:
	310	+	151
	311	+	2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB;
	312	+	152
	313	+	2C-B, Nexus;
	314	+	153
	315	+	(D) 2,5-dimethoxyamphetamine, some trade or other names: 2,5-dimethoxy-α
	316	+	154
	317	+	-methylphenethylamine; 2,5-DMA;
	318	+	155
	319	+	(E) 2,5-dimethoxy-4-ethylamphetamine, some trade or other names: DOET;
	320	+	156
	321	+	(F) 4-methoxyamphetamine, some trade or other names: 4-methoxy-α
	322	+	157
	323	+	-methylphenethylamine; paramethoxyamphetamine, PMA;
	324	+	158
	325	+	(G) 5-methoxy-3,4-methylenedioxyamphetamine;
	326	+	159
	327	+	(H) 4-methyl-2,5-dimethoxy-amphetamine, some trade and other names:
	328	+	160
	329	+	4-methyl-2,5-dimethoxy-α-methylphenethylamine; "DOM"; and "STP";
	330	+	161
	331	+	(I) 3,4-methylenedioxy amphetamine;
	332	+	162
	333	+	(J) 3,4-methylenedioxymethamphetamine (MDMA);
	334	+	163
	335	+	(K) 3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-
	336	+	164
	337	+	alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE,
	338	+	165
	339	+	MDEA;
	340	+	166
	341	+	(L) N-hydroxy-3,4-methylenedioxyamphetamine, also known as
	342	+	- 5 - H.B. 500 02-13 09:46
	343	+	167
	344	+	N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy
	345	+	168
	346	+	MDA;
	347	+	169
	348	+	(M) 3,4,5-trimethoxy amphetamine;
	349	+	170
	350	+	(N) Bufotenine, some trade and other names: 3-(β
	351	+	171
	352	+	-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol;
	353	+	172
	354	+	N, N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;
	355	+	173
	356	+	(O) Diethyltryptamine, some trade and other names: N,N-Diethyltryptamine; DET;
	357	+	174
	358	+	(P) Dimethyltryptamine, some trade or other names: DMT;
	359	+	175
	360	+	(Q) Ibogaine, some trade and other names: 7-Ethyl-6,6β
	361	+	176
	362	+	,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2]
	363	+	177
	364	+	azepino [5,4-b] indole; Tabernanthe iboga;
	365	+	178
	366	+	(R) Lysergic acid diethylamide;
	367	+	179
	368	+	(S) Marijuana;
	369	+	180
	370	+	(T) Mescaline;
	371	+	181
	372	+	(U) Parahexyl, some trade or other names:
	373	+	182
	374	+	3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran;
	375	+	183
	376	+	Synhexyl;
	377	+	184
	378	+	(V) Peyote, meaning all parts of the plant presently classified botanically as
	379	+	185
	380	+	Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any
	381	+	186
	382	+	extract from any part of such plant, and every compound, manufacture, salts,
	383	+	187
	384	+	derivative, mixture, or preparation of such plant, its seeds or extracts
	385	+	188
	386	+	(Interprets 21 USC 812(c), Schedule I(c) (12));
	387	+	189
	388	+	(W) N-ethyl-3-piperidyl benzilate;
	389	+	190
	390	+	(X) N-methyl-3-piperidyl benzilate;
	391	+	191
	392	+	(Y) Psilocybin;
	393	+	192
	394	+	(Z) Psilocyn;
	395	+	193
	396	+	(AA) Tetrahydrocannabinols, naturally contained in a plant of the genus Cannabis
	397	+	194
	398	+	(cannabis plant), except for marijuana as defined in Subsection 58-37-2
	399	+	195
	400	+	(1)(aa)(i)(E), as well as synthetic equivalents of the substances contained in the
	401	+	196
	402	+	cannabis plant, or in the resinous extractives of Cannabis, sp. and/or synthetic
	403	+	197
	404	+	substances, derivatives, and their isomers with similar chemical structure and
	405	+	198
	406	+	pharmacological activity to those substances contained in the plant, such as the
	407	+	199
	408	+	following: Δ1 cis or trans tetrahydrocannabinol, and their optical isomers Δ6 cis or
	409	+	200
	410	+	trans tetrahydrocannabinol, and their optical isomers Δ3,4 cis or trans
	411	+	- 6 - 02-13 09:46 H.B. 500
	412	+	201
	413	+	tetrahydrocannabinol, and its optical isomers, and since nomenclature of these
	414	+	202
	415	+	substances is not internationally standardized, compounds of these structures,
	416	+	203
	417	+	regardless of numerical designation of atomic positions covered;
	418	+	204
	419	+	(BB) Ethylamine analog of phencyclidine, some trade or other names:
	420	+	205
	421	+	N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine,
	422	+	206
	423	+	N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;
	424	+	207
	425	+	(CC) Pyrrolidine analog of phencyclidine, some trade or other names:
	426	+	208
	427	+	1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP;
	428	+	209
	429	+	(DD) Thiophene analog of phencyclidine, some trade or other names:
	430	+	210
	431	+	1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine,
	432	+	211
	433	+	TPCP, TCP; and
	434	+	212
	435	+	(EE) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, some other names: TCPy.
	436	+	213
	437	+	(iv) Unless specifically excepted or unless listed in another schedule, any material
	438	+	214
	439	+	compound, mixture, or preparation which contains any quantity of the following
	440	+	215
	441	+	substances having a depressant effect on the central nervous system, including its
	442	+	216
	443	+	salts, isomers, and salts of isomers when the existence of the salts, isomers, and
	444	+	217
	445	+	salts of isomers is possible within the specific chemical designation:
	446	+	218
	447	+	(A) Mecloqualone; and
	448	+	219
	449	+	(B) Methaqualone.
	450	+	220
	451	+	(v) Any material, compound, mixture, or preparation containing any quantity of the
	452	+	221
	453	+	following substances having a stimulant effect on the central nervous system,
	454	+	222
	455	+	including their salts, isomers, and salts of isomers:
	456	+	223
	457	+	(A) Aminorex, some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline;
	458	+	224
	459	+	or 4,5-dihydro-5-phenyl-2-oxazolamine;
	460	+	225
	461	+	(B) Cathinone, some trade or other names: 2-amino-1-phenyl-1-propanone,
	462	+	226
	463	+	alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone;
	464	+	227
	465	+	(C) Fenethylline;
	466	+	228
	467	+	(D) Methcathinone, some other names: 2-(methylamino)-propiophenone;
	468	+	229
	469	+	alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one;
	470	+	230
	471	+	alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone;
	472	+	231
	473	+	N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432,
	474	+	232
	475	+	its salts, optical isomers, and salts of optical isomers;
	476	+	233
	477	+	(E) (±)cis-4-methylaminorex ((±)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);
	478	+	234
	479	+	(F) N-ethylamphetamine; and
	480	+	- 7 - H.B. 500 02-13 09:46
	481	+	235
	482	+	(G) N,N-dimethylamphetamine, also known as
	483	+	236
	484	+	N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine.
	485	+	237
	486	+	(vi) Any material, compound, mixture, or preparation which contains any quantity of
	487	+	238
	488	+	the following substances, including their optical isomers, salts, and salts of
	489	+	239
	490	+	isomers, subject to temporary emergency scheduling:
	491	+	240
	492	+	(A) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl); and
	493	+	241
	494	+	(B) N-[1- (2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl).
	495	+	242
	496	+	(vii) Unless specifically excepted or unless listed in another schedule, any material,
	497	+	243
	498	+	compound, mixture, or preparation which contains any quantity of gamma
	499	+	244
	500	+	hydroxy butyrate (gamma hydrobutyric acid), including its salts, isomers, and
	501	+	245
	502	+	salts of isomers.
	503	+	246
	504	+	(b) Schedule II:
	505	+	247
62	506		(i) Unless specifically excepted or unless listed in another schedule, any of the
63		-	29
	507	+	248
	508	+	following substances whether produced directly or indirectly by extraction from
	509	+	249
	510	+	substances of vegetable origin, or independently by means of chemical synthesis,
	511	+	250
	512	+	or by a combination of extraction and chemical synthesis:
	513	+	251
	514	+	(A) Opium and opiate, and any salt, compound, derivative, or preparation of
	515	+	252
	516	+	opium or opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene,
	517	+	253
	518	+	naloxone, and naltrexone, and their respective salts, but including:
	519	+	254
	520	+	(I) Raw opium;
	521	+	255
	522	+	(II) Opium extracts;
	523	+	256
	524	+	(III) Opium fluid;
	525	+	257
	526	+	(IV) Powdered opium;
	527	+	258
	528	+	(V) Granulated opium;
	529	+	259
	530	+	(VI) Tincture of opium;
	531	+	260
	532	+	(VII) Codeine;
	533	+	261
	534	+	(VIII) Ethylmorphine;
	535	+	262
	536	+	(IX) Etorphine hydrochloride;
	537	+	263
	538	+	(X) Hydrocodone;
	539	+	264
	540	+	(XI) Hydromorphone;
	541	+	265
	542	+	(XII) Metopon;
	543	+	266
	544	+	(XIII) Morphine;
	545	+	267
	546	+	(XIV) Oxycodone;
	547	+	268
	548	+	(XV) Oxymorphone; and
	549	+	- 8 - 02-13 09:46 H.B. 500
	550	+	269
	551	+	(XVI) Thebaine;
	552	+	270
	553	+	(B) Any salt, compound, derivative, or preparation which is chemically equivalent
	554	+	271
	555	+	or identical with any of the substances referred to in Subsection (2)(b)(i)(A),
	556	+	272
	557	+	except that these substances may not include the isoquinoline alkaloids of
	558	+	273
	559	+	opium;
	560	+	274
	561	+	(C) Opium poppy and poppy straw;
	562	+	275
	563	+	(D) Coca leaves and any salt, compound, derivative, or preparation of coca leaves,
	564	+	276
	565	+	and any salt, compound, derivative, or preparation which is chemically
	566	+	277
	567	+	equivalent or identical with any of these substances, and includes cocaine and
	568	+	278
	569	+	ecgonine, their salts, isomers, derivatives, and salts of isomers and derivatives,
	570	+	279
	571	+	whether derived from the coca plant or synthetically produced, except the
	572	+	280
	573	+	substances may not include decocainized coca leaves or extraction of coca
	574	+	281
	575	+	leaves, which extractions do not contain cocaine or ecgonine; and
	576	+	282
	577	+	(E) Concentrate of poppy straw, which means the crude extract of poppy straw in
	578	+	283
	579	+	either liquid, solid, or powder form which contains the phenanthrene alkaloids
	580	+	284
	581	+	of the opium poppy.
	582	+	285
	583	+	(ii) Unless specifically excepted or unless listed in another schedule, any of the
	584	+	286
64	585		following opiates, including their isomers, esters, ethers, salts, and salts of
65		-	1st Sub. H.B. 500 1st Sub. (Buff) H.B. 500 03-05 12:19
66		-	30
	586	+	287
67	587		isomers, esters, and ethers, when the existence of the isomers, esters, ethers, and
68		-	31
69		-	salts is possible within the specific chemical designation:
70		-	32
71		-	(A) Acetyl-alpha-methylfentanyl
72		-	33
73		-	(N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
74		-	34
75		-	(B) Acetyl fentanyl: (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);
76		-	35
77		-	(C) Acetylmethadol;
78		-	36
79		-	(D) Acryl fentanyl (N-(1-Phenethylpiperidin-4-yl)-N-phenylacrylamide);
80		-	37
81		-	(E) Allylprodine;
82		-	38
83		-	(F) Alphacetylmethadol, except levo-alphacetylmethadol also known as
84		-	39
85		-	levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;
86		-	40
87		-	(G) Alphameprodine;
88		-	41
89		-	(H) Alphamethadol;
90		-	42
91		-	(I) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]
92		-	43
93		-	propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);
94		-	44
95		-	(J) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-
96		-	45
97		-	piperidinyl]-N-phenylpropanamide);
98		-	46
99		-	(K) Benzylpiperazine;
100		-	47
101		-	(L) Benzethidine;
102		-	48
103		-	(M) Betacetylmethadol;
104		-	49
105		-	(N) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-
106		-	50
107		-	piperidinyl]-N-phenylpropanamide);
108		-	51
109		-	(O) Beta-hydroxy-3-methylfentanyl, other name: N-[1-(2-hydroxy-2-
110		-	52
111		-	phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide;
112		-	53
113		-	(P) Betameprodine;
114		-	54
115		-	(Q) Betamethadol;
116		-	55
117		-	(R) Betaprodine;
118		-	56
119		-	(S) Butyryl fentanyl (N-(1-(2-phenylethyl)-4-piperidinyl)-N-phenylbutyramide);
120		-	57
121		-	(T) Clonitazene;
122		-	58
123		-	(U) Cyclopropyl fentanyl
124		-	59
125		-	(N-(1-Phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide);
126		-	60
127		-	(V) Dextromoramide;
128		-	61
129		-	(W) Diampromide;
130		-	62
131		-	(X) Diethylthiambutene;
132		-	63
133		-	(Y) Difenoxin;
134		-	- 2 - 03-05 12:19 1st Sub. (Buff) H.B. 500
135		-	64
136		-	(Z) Dimenoxadol;
137		-	65
138		-	(AA) Dimepheptanol;
139		-	66
140		-	(BB) Dimethylthiambutene;
141		-	67
142		-	(CC) Dioxaphetyl butyrate;
143		-	68
144		-	(DD) Dipipanone;
145		-	69
146		-	(EE) Ethylmethylthiambutene;
147		-	70
148		-	(FF) Etizolam
149		-	71
150		-	(1-Methyl-6-o-chlorophenyl-8-ethyl-4H-s-triazolo[3,4-c]thieno[2,3-e]1,4-diazepine);
151		-	72
152		-	(GG) Etonitazene;
153		-	73
154		-	(HH) Etoxeridine;
155		-	74
156		-	(II) Furanyl fentanyl (N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]
157		-	75
158		-	furan-2-carboxamide);
159		-	76
160		-	(JJ) Furethidine;
161		-	77
162		-	(KK) Hydroxypethidine;
163		-	78
164		-	(LL) Ketobemidone;
165		-	79
166		-	(MM) Levomoramide;
167		-	80
168		-	(NN) Levophenacylmorphan;
169		-	81
170		-	(OO) Methoxyacetyl fentanyl
171		-	82
172		-	(2-Methoxy-N-(1-phenylethylpiperidinyl-4-yl)-N-acetamide);
173		-	83
174		-	(PP) Morpheridine;
175		-	84
176		-	(QQ) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
177		-	85
178		-	(RR) Noracymethadol;
179		-	86
180		-	(SS) Norlevorphanol;
181		-	87
182		-	(TT) Normethadone;
183		-	88
184		-	(UU) Norpipanone;
185		-	89
186		-	(VV) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4- piperidinyl]
187		-	90
188		-	propanamide);
189		-	91
190		-	(WW) Para-fluoroisobutyryl fentanyl
191		-	92
192		-	(N-(4-Fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);
193		-	93
194		-	(XX) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
195		-	94
196		-	(YY) Phenadoxone;
197		-	95
198		-	(ZZ) Phenampromide;
199		-	96
200		-	(AAA) Phenomorphan;
201		-	97
202		-	(BBB) Phenoperidine;
203		-	- 3 - 1st Sub. (Buff) H.B. 500 03-05 12:19
204		-	98
205		-	(CCC) Piritramide;
206		-	99
207		-	(DDD) Proheptazine;
208		-	100
209		-	(EEE) Properidine;
210		-	101
211		-	(FFF) Propiram;
212		-	102
213		-	(GGG) Racemoramide;
214		-	103
215		-	(HHH) Tetrahydrofuran fentanyl
216		-	104
217		-	(N-(1-Phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide);
218		-	105
219		-	(III) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]- propanamide;
220		-	106
221		-	(JJJ) Tilidine;
222		-	107
223		-	(KKK) Trimeperidine;
224		-	108
225		-	(LLL) 3-methylfentanyl, including the optical and geometric isomers
226		-	109
227		-	(N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N-phenylpropanamide);
228		-	110
229		-	(MMM) 3-methylthiofentanyl
230		-	111
231		-	(N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
232		-	112
233		-	(NNN) 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide also
234		-	113
235		-	known as U-47700; and
236		-	114
237		-	(OOO) 4-cyano CUMYL-BUTINACA.
238		-	115
239		-	(ii) Unless specifically excepted or unless listed in another schedule, any of the
240		-	116
241		-	following opium derivatives, their salts, isomers, and salts of isomers when the
242		-	117
243		-	existence of the salts, isomers, and salts of isomers is possible within the specific
244		-	118
245		-	chemical designation:
246		-	119
247		-	(A) Acetorphine;
248		-	120
249		-	(B) Acetyldihydrocodeine;
250		-	121
251		-	(C) Benzylmorphine;
252		-	122
253		-	(D) Codeine methylbromide;
254		-	123
255		-	(E) Codeine-N-Oxide;
256		-	124
257		-	(F) Cyprenorphine;
258		-	125
259		-	(G) Desomorphine;
260		-	126
261		-	(H) Dihydromorphine;
262		-	127
263		-	(I) Drotebanol;
264		-	128
265		-	(J) Etorphine (except hydrochloride salt);
266		-	129
267		-	(K) Heroin;
268		-	130
269		-	(L) Hydromorphinol;
270		-	131
271		-	(M) Methyldesorphine;
272		-	- 4 - 03-05 12:19 1st Sub. (Buff) H.B. 500
273		-	132
274		-	(N) Methylhydromorphine;
275		-	133
276		-	(O) Morphine methylbromide;
277		-	134
278		-	(P) Morphine methylsulfonate;
279		-	135
280		-	(Q) Morphine-N-Oxide;
281		-	136
282		-	(R) Myrophine;
283		-	137
284		-	(S) Nicocodeine;
285		-	138
286		-	(T) Nicomorphine;
287		-	139
288		-	(U) Normorphine;
289		-	140
290		-	(V) Pholcodine; and
291		-	141
292		-	(W) Thebacon.
293		-	142
	588	+	288
	589	+	salts is possible within the specific chemical designation, except dextrorphan and
	590	+	289
	591	+	levopropoxyphene:
	592	+	290
	593	+	(A) Alfentanil;
	594	+	291
	595	+	(B) Alphaprodine;
	596	+	292
	597	+	(C) Anileridine;
	598	+	293
	599	+	(D) Bezitramide;
	600	+	294
	601	+	(E) Bulk dextropropoxyphene (nondosage forms);
	602	+	295
	603	+	(F) Carfentanil;
	604	+	296
	605	+	(G) Dihydrocodeine;
	606	+	297
	607	+	(H) Diphenoxylate;
	608	+	298
	609	+	(I) Fentanyl;
	610	+	299
	611	+	(J) Isomethadone;
	612	+	300
	613	+	(K) Levo-alphacetylmethadol, some other names: levo-alpha-acetylmethadol,
	614	+	301
	615	+	levomethadyl acetate, or LAAM;
	616	+	302
	617	+	(L) Levomethorphan;
	618	+	- 9 - H.B. 500 02-13 09:46
	619	+	303
	620	+	(M) Levorphanol;
	621	+	304
	622	+	(N) Metazocine;
	623	+	305
	624	+	(O) Methadone;
	625	+	306
	626	+	(P) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
	627	+	307
	628	+	(Q) Moramide-Intermediate, 2-methyl-3-morpholino-1,
	629	+	308
	630	+	1-diphenylpropane-carboxylic acid;
	631	+	309
	632	+	(R) Pethidine (meperidine);
	633	+	310
	634	+	(S) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;
	635	+	311
	636	+	(T) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;
	637	+	312
	638	+	(U) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
	639	+	313
	640	+	(V) Phenazocine;
	641	+	314
	642	+	(W) Piminodine;
	643	+	315
	644	+	(X) Racemethorphan;
	645	+	316
	646	+	(Y) Racemorphan;
	647	+	317
	648	+	(Z) Remifentanil; and
	649	+	318
	650	+	(AA) Sufentanil.
	651	+	319
294	652		(iii) Unless specifically excepted or unless listed in another schedule, any material,
295		-	~~143~~
	653	+	320
296	654		compound, mixture, or preparation which contains any quantity of the following
297		-	144
298		-	hallucinogenic substances, or which contains any of their salts, isomers, and salts
299		-	145
300		-	of isomers when the existence of the salts, isomers, and salts of isomers is possible
301		-	146
302		-	within the specific chemical designation; as used in this Subsection (2)(a)(iii)
303		-	147
304		-	only, "isomer" includes the optical, position, and geometric isomers:
305		-	148
306		-	(A) Alpha-ethyltryptamine, some trade or other names: etryptamine; Monase; α
307		-	149
308		-	-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; α-ET; and AET;
309		-	150
310		-	(B) 4-bromo-2,5-dimethoxy-amphetamine, some trade or other names:
311		-	151
312		-	4-bromo-2,5-dimethoxy-α-methylphenethylamine; 4-bromo-2,5-DMA;
313		-	152
314		-	(C) 4-bromo-2,5-dimethoxyphenethylamine, some trade or other names:
315		-	153
316		-	2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB;
317		-	154
318		-	2C-B, Nexus;
319		-	155
320		-	(D) 2,5-dimethoxyamphetamine, some trade or other names: 2,5-dimethoxy-α
321		-	156
322		-	-methylphenethylamine; 2,5-DMA;
323		-	157
324		-	(E) 2,5-dimethoxy-4-ethylamphetamine, some trade or other names: DOET;
325		-	158
326		-	(F) 4-methoxyamphetamine, some trade or other names: 4-methoxy-α
327		-	159
328		-	-methylphenethylamine; paramethoxyamphetamine, PMA;
329		-	160
330		-	(G) 5-methoxy-3,4-methylenedioxyamphetamine;
331		-	161
332		-	(H) 4-methyl-2,5-dimethoxy-amphetamine, some trade and other names:
333		-	162
334		-	4-methyl-2,5-dimethoxy-α-methylphenethylamine; "DOM"; and "STP";
335		-	163
336		-	(I) 3,4-methylenedioxy amphetamine;
337		-	164
338		-	(J) 3,4-methylenedioxymethamphetamine (MDMA);
339		-	165
340		-	(K) 3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-
341		-	- 5 - 1st Sub. (Buff) H.B. 500 03-05 12:19
342		-	166
343		-	alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE,
344		-	167
345		-	MDEA;
346		-	168
347		-	(L) N-hydroxy-3,4-methylenedioxyamphetamine, also known as
348		-	169
349		-	N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy
350		-	170
351		-	MDA;
352		-	171
353		-	(M) 3,4,5-trimethoxy amphetamine;
354		-	172
355		-	(N) Bufotenine, some trade and other names: 3-(β
356		-	173
357		-	-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol;
358		-	174
359		-	N, N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;
360		-	175
361		-	(O) Diethyltryptamine, some trade and other names: N,N-Diethyltryptamine; DET;
362		-	176
363		-	(P) Dimethyltryptamine, some trade or other names: DMT;
364		-	177
365		-	(Q) Ibogaine, some trade and other names: 7-Ethyl-6,6β
366		-	178
367		-	,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2]
368		-	179
369		-	azepino [5,4-b] indole; Tabernanthe iboga;
370		-	180
371		-	(R) Lysergic acid diethylamide;
372		-	181
373		-	(S) Marijuana;
374		-	182
375		-	(T) Mescaline;
376		-	183
377		-	(U) Parahexyl, some trade or other names:
378		-	184
379		-	3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran;
380		-	185
381		-	Synhexyl;
382		-	186
383		-	(V) Peyote, meaning all parts of the plant presently classified botanically as
384		-	187
385		-	Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any
386		-	188
387		-	extract from any part of such plant, and every compound, manufacture, salts,
388		-	189
389		-	derivative, mixture, or preparation of such plant, its seeds or extracts
390		-	190
391		-	(Interprets 21 USC 812(c), Schedule I(c) (12));
392		-	191
393		-	(W) N-ethyl-3-piperidyl benzilate;
394		-	192
395		-	(X) N-methyl-3-piperidyl benzilate;
396		-	193
397		-	(Y) Psilocybin, except as provided in Subsection (3);
398		-	194
399		-	(Z) Psilocyn;
400		-	195
401		-	(AA) Tetrahydrocannabinols, naturally contained in a plant of the genus Cannabis
402		-	196
403		-	(cannabis plant), except for marijuana as defined in Subsection 58-37-2
404		-	197
405		-	(1)(aa)(i)(E), as well as synthetic equivalents of the substances contained in the
406		-	198
407		-	cannabis plant, or in the resinous extractives of Cannabis, sp. and/or synthetic
408		-	199
409		-	substances, derivatives, and their isomers with similar chemical structure and
410		-	- 6 - 03-05 12:19 1st Sub. (Buff) H.B. 500
411		-	200
412		-	pharmacological activity to those substances contained in the plant, such as the
413		-	201
414		-	following: Δ1 cis or trans tetrahydrocannabinol, and their optical isomers Δ6 cis or
415		-	202
416		-	trans tetrahydrocannabinol, and their optical isomers Δ3,4 cis or trans
417		-	203
418		-	tetrahydrocannabinol, and its optical isomers, and since nomenclature of these
419		-	204
420		-	substances is not internationally standardized, compounds of these structures,
421		-	205
422		-	regardless of numerical designation of atomic positions covered;
423		-	206
424		-	(BB) Ethylamine analog of phencyclidine, some trade or other names:
425		-	207
426		-	N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine,
427		-	208
428		-	N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;
429		-	209
430		-	(CC) Pyrrolidine analog of phencyclidine, some trade or other names:
431		-	210
432		-	1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP;
433		-	211
434		-	(DD) Thiophene analog of phencyclidine, some trade or other names:
435		-	212
436		-	1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine,
437		-	213
438		-	TPCP, TCP; and
439		-	214
440		-	(EE) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, some other names: TCPy.
441		-	215
442		-	(iv) Unless specifically excepted or unless listed in another schedule, any material
443		-	216
	655	+	321
	656	+	substances having a stimulant effect on the central nervous system:
	657	+	322
	658	+	(A) Amphetamine, its salts, optical isomers, and salts of its optical isomers;
	659	+	323
	660	+	(B) Methamphetamine, its salts, isomers, and salts of its isomers;
	661	+	324
	662	+	(C) Phenmetrazine and its salts; and
	663	+	325
	664	+	(D) Methylphenidate.
	665	+	326
	666	+	(iv) Unless specifically excepted or unless listed in another schedule, any material,
	667	+	327
444	668		compound, mixture, or preparation which contains any quantity of the following
445		-	~~217~~
	669	+	328
446	670		substances having a depressant effect on the central nervous system, including its
447		-	~~218~~
	671	+	329
448	672		salts, isomers, and salts of isomers when the existence of the salts, isomers, and
449		-	~~219~~
	673	+	330
450	674		salts of isomers is possible within the specific chemical designation:
451		-	220
452		-	(A) Mecloqualone; and
453		-	221
454		-	(B) Methaqualone.
455		-	222
456		-	(v) Any material, compound, mixture, or preparation containing any quantity of the
457		-	223
458		-	following substances having a stimulant effect on the central nervous system,
459		-	224
460		-	including their salts, isomers, and salts of isomers:
461		-	225
462		-	(A) Aminorex, some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline;
463		-	226
464		-	or 4,5-dihydro-5-phenyl-2-oxazolamine;
465		-	227
466		-	(B) Cathinone, some trade or other names: 2-amino-1-phenyl-1-propanone,
467		-	228
468		-	alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone;
469		-	229
470		-	(C) Fenethylline;
471		-	230
472		-	(D) Methcathinone, some other names: 2-(methylamino)-propiophenone;
473		-	231
474		-	alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one;
475		-	232
476		-	alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone;
477		-	233
478		-	N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432,
479		-	- 7 - 1st Sub. (Buff) H.B. 500 03-05 12:19
480		-	234
481		-	its salts, optical isomers, and salts of optical isomers;
482		-	235
483		-	(E) (±)cis-4-methylaminorex ((±)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);
484		-	236
485		-	(F) N-ethylamphetamine; and
486		-	237
487		-	(G) N,N-dimethylamphetamine, also known as
488		-	238
489		-	N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine.
490		-	239
491		-	(vi) Any material, compound, mixture, or preparation which contains any quantity of
492		-	240
493		-	the following substances, including their optical isomers, salts, and salts of
494		-	241
495		-	isomers, subject to temporary emergency scheduling:
496		-	242
497		-	(A) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl); and
498		-	243
499		-	(B) N-[1- (2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl).
500		-	244
501		-	(vii) Unless specifically excepted or unless listed in another schedule, any material,
502		-	245
503		-	compound, mixture, or preparation which contains any quantity of gamma
504		-	246
505		-	hydroxy butyrate (gamma hydrobutyric acid), including its salts, isomers, and
506		-	247
507		-	salts of isomers.
508		-	248
509		-	(b) Schedule II:
510		-	249
511		-	(i) Unless specifically excepted or unless listed in another schedule, any of the
512		-	250
513		-	following substances whether produced directly or indirectly by extraction from
514		-	251
515		-	substances of vegetable origin, or independently by means of chemical synthesis,
516		-	252
517		-	or by a combination of extraction and chemical synthesis:
518		-	253
519		-	(A) Opium and opiate, and any salt, compound, derivative, or preparation of
520		-	254
521		-	opium or opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene,
522		-	255
523		-	naloxone, and naltrexone, and their respective salts, but including:
524		-	256
525		-	(I) Raw opium;
526		-	257
527		-	(II) Opium extracts;
528		-	258
529		-	(III) Opium fluid;
530		-	259
531		-	(IV) Powdered opium;
532		-	260
533		-	(V) Granulated opium;
534		-	261
535		-	(VI) Tincture of opium;
536		-	262
537		-	(VII) Codeine;
538		-	263
539		-	(VIII) Ethylmorphine;
540		-	264
541		-	(IX) Etorphine hydrochloride;
542		-	265
543		-	(X) Hydrocodone;
544		-	266
545		-	(XI) Hydromorphone;
546		-	267
547		-	(XII) Metopon;
548		-	- 8 - 03-05 12:19 1st Sub. (Buff) H.B. 500
549		-	268
550		-	(XIII) Morphine;
551		-	269
552		-	(XIV) Oxycodone;
553		-	270
554		-	(XV) Oxymorphone; and
555		-	271
556		-	(XVI) Thebaine;
557		-	272
558		-	(B) Any salt, compound, derivative, or preparation which is chemically equivalent
559		-	273
560		-	or identical with any of the substances referred to in Subsection (2)(b)(i)(A),
561		-	274
562		-	except that these substances may not include the isoquinoline alkaloids of
563		-	275
564		-	opium;
565		-	276
566		-	(C) Opium poppy and poppy straw;
567		-	277
568		-	(D) Coca leaves and any salt, compound, derivative, or preparation of coca leaves,
569		-	278
570		-	and any salt, compound, derivative, or preparation which is chemically
571		-	279
572		-	equivalent or identical with any of these substances, and includes cocaine and
573		-	280
574		-	ecgonine, their salts, isomers, derivatives, and salts of isomers and derivatives,
575		-	281
576		-	whether derived from the coca plant or synthetically produced, except the
577		-	282
578		-	substances may not include decocainized coca leaves or extraction of coca
579		-	283
580		-	leaves, which extractions do not contain cocaine or ecgonine; and
581		-	284
582		-	(E) Concentrate of poppy straw, which means the crude extract of poppy straw in
583		-	285
584		-	either liquid, solid, or powder form which contains the phenanthrene alkaloids
585		-	286
586		-	of the opium poppy.
587		-	287
588		-	(ii) Unless specifically excepted or unless listed in another schedule, any of the
589		-	288
590		-	following opiates, including their isomers, esters, ethers, salts, and salts of
591		-	289
592		-	isomers, esters, and ethers, when the existence of the isomers, esters, ethers, and
593		-	290
594		-	salts is possible within the specific chemical designation, except dextrorphan and
595		-	291
596		-	levopropoxyphene:
597		-	292
598		-	(A) Alfentanil;
599		-	293
600		-	(B) Alphaprodine;
601		-	294
602		-	(C) Anileridine;
603		-	295
604		-	(D) Bezitramide;
605		-	296
606		-	(E) Bulk dextropropoxyphene (nondosage forms);
607		-	297
608		-	(F) Carfentanil;
609		-	298
610		-	(G) Dihydrocodeine;
611		-	299
612		-	(H) Diphenoxylate;
613		-	300
614		-	(I) Fentanyl;
615		-	301
616		-	(J) Isomethadone;
617		-	- 9 - 1st Sub. (Buff) H.B. 500 03-05 12:19
618		-	302
619		-	(K) Levo-alphacetylmethadol, some other names: levo-alpha-acetylmethadol,
620		-	303
621		-	levomethadyl acetate, or LAAM;
622		-	304
623		-	(L) Levomethorphan;
624		-	305
625		-	(M) Levorphanol;
626		-	306
627		-	(N) Metazocine;
628		-	307
629		-	(O) Methadone;
630		-	308
631		-	(P) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
632		-	309
633		-	(Q) Moramide-Intermediate, 2-methyl-3-morpholino-1,
634		-	310
635		-	1-diphenylpropane-carboxylic acid;
636		-	311
637		-	(R) Pethidine (meperidine);
638		-	312
639		-	(S) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;
640		-	313
641		-	(T) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;
642		-	314
643		-	(U) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
644		-	315
645		-	(V) Phenazocine;
646		-	316
647		-	(W) Piminodine;
648		-	317
649		-	(X) Racemethorphan;
650		-	318
651		-	(Y) Racemorphan;
652		-	319
653		-	(Z) Remifentanil; and
654		-	320
655		-	(AA) Sufentanil.
656		-	321
657		-	(iii) Unless specifically excepted or unless listed in another schedule, any material,
658		-	322
	675	+	331
	676	+	(A) Amobarbital;
	677	+	332
	678	+	(B) Glutethimide;
	679	+	333
	680	+	(C) Pentobarbital;
	681	+	334
	682	+	(D) Phencyclidine;
	683	+	335
	684	+	(E) Phencyclidine immediate precursors: 1-phenylcyclohexylamine and
	685	+	336
	686	+	1-piperidinocyclohexanecarbonitrile (PCC); and
	687	+	- 10 - 02-13 09:46 H.B. 500
	688	+	337
	689	+	(F) Secobarbital.
	690	+	338
	691	+	(v)(A) Unless specifically excepted or unless listed in another schedule, any
	692	+	339
	693	+	material, compound, mixture, or preparation which contains any quantity of
	694	+	340
	695	+	Phenylacetone.
	696	+	341
	697	+	(B) Some of these substances may be known by trade or other names:
	698	+	342
	699	+	phenyl-2-propanone; P2P; benzyl methyl ketone; and methyl benzyl ketone.
	700	+	343
	701	+	(vi) Nabilone, another name for nabilone: (±
	702	+	344
	703	+	)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,
	704	+	345
	705	+	6-dimethyl-9H-dibenzo[b,d]pyran-9-one.
	706	+	346
	707	+	(vii) A drug product or preparation that contains any component of marijuana,
	708	+	347
	709	+	including tetrahydrocannabinol, and is approved by the United States Food and
	710	+	348
	711	+	Drug Administration and scheduled by the Drug Enforcement Administration in
	712	+	349
	713	+	Schedule II of the federal Controlled Substances Act, Title II, P.L. 91-513.
	714	+	350
	715	+	(c) Schedule III:
	716	+	351
	717	+	(i) Unless specifically excepted or unless listed in another schedule, any material,
	718	+	352
659	719		compound, mixture, or preparation which contains any quantity of the following
660		-	323
661		-	substances having a stimulant effect on the central nervous system:
662		-	324
663		-	(A) Amphetamine, its salts, optical isomers, and salts of its optical isomers;
664		-	325
665		-	(B) Methamphetamine, its salts, isomers, and salts of its isomers;
666		-	326
667		-	(C) Phenmetrazine and its salts; and
668		-	327
669		-	(D) Methylphenidate.
670		-	328
	720	+	353
	721	+	substances having a stimulant effect on the central nervous system, including its
	722	+	354
	723	+	salts, isomers whether optical, position, or geometric, and salts of the isomers
	724	+	355
	725	+	when the existence of the salts, isomers, and salts of isomers is possible within the
	726	+	356
	727	+	specific chemical designation:
	728	+	357
	729	+	(A) Those compounds, mixtures, or preparations in dosage unit form containing
	730	+	358
	731	+	any stimulant substances listed in Schedule II, which compounds, mixtures, or
	732	+	359
	733	+	preparations were listed on August 25, 1971, as excepted compounds under
	734	+	360
	735	+	Section 1308.32 of Title 21 of the Code of Federal Regulations, and any other
	736	+	361
	737	+	drug of the quantitive composition shown in that list for those drugs or which
	738	+	362
	739	+	is the same except that it contains a lesser quantity of controlled substances;
	740	+	363
	741	+	(B) Benzphetamine;
	742	+	364
	743	+	(C) Chlorphentermine;
	744	+	365
	745	+	(D) Clortermine; and
	746	+	366
	747	+	(E) Phendimetrazine.
	748	+	367
	749	+	(ii) Unless specifically excepted or unless listed in another schedule, any material,
	750	+	368
	751	+	compound, mixture, or preparation which contains any quantity of the following
	752	+	369
	753	+	substances having a depressant effect on the central nervous system:
	754	+	370
	755	+	(A) Any compound, mixture, or preparation containing amobarbital, secobarbital,
	756	+	- 11 - H.B. 500 02-13 09:46
	757	+	371
	758	+	pentobarbital, or any salt of any of them, and one or more other active
	759	+	372
	760	+	medicinal ingredients which are not listed in any schedule;
	761	+	373
	762	+	(B) Any suppository dosage form containing amobarbital, secobarbital, or
	763	+	374
	764	+	pentobarbital, or any salt of any of these drugs which is approved by the United
	765	+	375
	766	+	States Food and Drug Administration for marketing only as a suppository;
	767	+	376
	768	+	(C) Any substance which contains any quantity of a derivative of barbituric acid
	769	+	377
	770	+	or any salt of any of them;
	771	+	378
	772	+	(D) Chlorhexadol;
	773	+	379
	774	+	(E) Buprenorphine;
	775	+	380
	776	+	(F) Any drug product containing gamma hydroxybutyric acid, including its salts,
	777	+	381
	778	+	isomers, and salts of isomers, for which an application is approved under the
	779	+	382
	780	+	federal Food, Drug, and Cosmetic Act, Section 505;
	781	+	383
	782	+	(G) Ketamine, its salts, isomers, and salts of isomers, some other names for
	783	+	384
	784	+	ketamine: ± -2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone;
	785	+	385
	786	+	(H) Lysergic acid;
	787	+	386
	788	+	(I) Lysergic acid amide;
	789	+	387
	790	+	(J) Methyprylon;
	791	+	388
	792	+	(K) Sulfondiethylmethane;
	793	+	389
	794	+	(L) Sulfonethylmethane;
	795	+	390
	796	+	(M) Sulfonmethane; and
	797	+	391
	798	+	(N) Tiletamine and zolazepam or any of their salts, some trade or other names for
	799	+	392
	800	+	a tiletamine-zolazepam combination product: Telazol, some trade or other
	801	+	393
	802	+	names for tiletamine: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone, some trade
	803	+	394
	804	+	or other names for zolazepam:
	805	+	395
	806	+	4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e]
	807	+	396
	808	+	[1,4]-diazepin-7(1H)-one, flupyrazapon.
	809	+	397
	810	+	(iii) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in
	811	+	398
	812	+	a U.S. Food and Drug Administration approved drug product, some other names
	813	+	399
	814	+	for dronabinol:
	815	+	400
	816	+	(6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol,
	817	+	401
	818	+	or (-)-delta-9-(trans)-tetrahydrocannabinol.
	819	+	402
	820	+	(iv) Nalorphine.
	821	+	403
	822	+	(v) Unless specifically excepted or unless listed in another schedule, any material,
	823	+	404
	824	+	compound, mixture, or preparation containing limited quantities of any of the
	825	+	- 12 - 02-13 09:46 H.B. 500
	826	+	405
	827	+	following narcotic drugs, or their salts calculated as the free anhydrous base or
	828	+	406
	829	+	alkaloid:
	830	+	407
	831	+	(A) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
	832	+	408
	833	+	milligrams per dosage unit, with an equal or greater quantity of an isoquinoline
	834	+	409
	835	+	alkaloid of opium;
	836	+	410
	837	+	(B) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
	838	+	411
	839	+	milligrams per dosage unit, with one or more active non-narcotic ingredients in
	840	+	412
	841	+	recognized therapeutic amounts;
	842	+	413
	843	+	(C) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not
	844	+	414
	845	+	more than 15 milligrams per dosage unit, with a fourfold or greater quantity of
	846	+	415
	847	+	an isoquinoline alkaloid of opium;
	848	+	416
	849	+	(D) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not
	850	+	417
	851	+	more than 15 milligrams per dosage unit, with one or more active, non-narcotic
	852	+	418
	853	+	ingredients in recognized therapeutic amounts;
	854	+	419
	855	+	(E) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more
	856	+	420
	857	+	than 90 milligrams per dosage unit, with one or more active non-narcotic
	858	+	421
	859	+	ingredients in recognized therapeutic amounts;
	860	+	422
	861	+	(F) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more
	862	+	423
	863	+	than 15 milligrams per dosage unit, with one or more active, non-narcotic
	864	+	424
	865	+	ingredients in recognized therapeutic amounts;
	866	+	425
	867	+	(G) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams,
	868	+	426
	869	+	or not more than 25 milligrams per dosage unit, with one or more active,
	870	+	427
	871	+	non-narcotic ingredients in recognized therapeutic amounts; and
	872	+	428
	873	+	(H) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams
	874	+	429
	875	+	with one or more active, non-narcotic ingredients in recognized therapeutic
	876	+	430
	877	+	amounts.
	878	+	431
	879	+	(vi) Unless specifically excepted or unless listed in another schedule, anabolic
	880	+	432
	881	+	steroids including any of the following or any isomer, ester, salt, or derivative of
	882	+	433
	883	+	the following that promotes muscle growth:
	884	+	434
	885	+	(A) Boldenone;
	886	+	435
	887	+	(B) Chlorotestosterone (4-chlortestosterone);
	888	+	436
	889	+	(C) Clostebol;
	890	+	437
	891	+	(D) Dehydrochlormethyltestosterone;
	892	+	438
	893	+	(E) Dihydrotestosterone (4-dihydrotestosterone);
	894	+	- 13 - H.B. 500 02-13 09:46
	895	+	439
	896	+	(F) Drostanolone;
	897	+	440
	898	+	(G) Ethylestrenol;
	899	+	441
	900	+	(H) Fluoxymesterone;
	901	+	442
	902	+	(I) Formebulone (formebolone);
	903	+	443
	904	+	(J) Mesterolone;
	905	+	444
	906	+	(K) Methandienone;
	907	+	445
	908	+	(L) Methandranone;
	909	+	446
	910	+	(M) Methandriol;
	911	+	447
	912	+	(N) Methandrostenolone;
	913	+	448
	914	+	(O) Methenolone;
	915	+	449
	916	+	(P) Methyltestosterone;
	917	+	450
	918	+	(Q) Mibolerone;
	919	+	451
	920	+	(R) Nandrolone;
	921	+	452
	922	+	(S) Norethandrolone;
	923	+	453
	924	+	(T) Oxandrolone;
	925	+	454
	926	+	(U) Oxymesterone;
	927	+	455
	928	+	(V) Oxymetholone;
	929	+	456
	930	+	(W) Stanolone;
	931	+	457
	932	+	(X) Stanozolol;
	933	+	458
	934	+	(Y) Testolactone;
	935	+	459
	936	+	(Z) Testosterone; and
	937	+	460
	938	+	(AA) Trenbolone.
	939	+	461
	940	+	(vii) Anabolic steroids expressly intended for administration through implants to
	941	+	462
	942	+	cattle or other nonhuman species, and approved by the Secretary of Health and
	943	+	463
	944	+	Human Services for use, may not be classified as a controlled substance.
	945	+	464
	946	+	(viii) A drug product or preparation that contains any component of marijuana,
	947	+	465
	948	+	including tetrahydrocannabinol, and is approved by the United States Food and
	949	+	466
	950	+	Drug Administration and scheduled by the Drug Enforcement Administration in
	951	+	467
	952	+	Schedule III of the federal Controlled Substances Act, Title II, P.L. 91-513.
	953	+	468
	954	+	(ix) Nabiximols.
	955	+	469
	956	+	(x) Amanita Muscaria.
	957	+	470
	958	+	(d) Schedule IV:
	959	+	471
	960	+	(i) Unless specifically excepted or unless listed in another schedule, any material,
	961	+	472
	962	+	compound, mixture, or preparation containing not more than 1 milligram of
	963	+	- 14 - 02-13 09:46 H.B. 500
	964	+	473
	965	+	difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit, or
	966	+	474
	967	+	any salts of any of them.
	968	+	475
	969	+	(ii) Unless specifically excepted or unless listed in another schedule, any material,
	970	+	476
	971	+	compound, mixture, or preparation which contains any quantity of the following
	972	+	477
	973	+	substances, including its salts, isomers, and salts of isomers when the existence of
	974	+	478
	975	+	the salts, isomers, and salts of isomers is possible within the specific chemical
	976	+	479
	977	+	designation:
	978	+	480
	979	+	(A) Alprazolam;
	980	+	481
	981	+	(B) Barbital;
	982	+	482
	983	+	(C) Bromazepam;
	984	+	483
	985	+	(D) Butorphanol;
	986	+	484
	987	+	(E) Camazepam;
	988	+	485
	989	+	(F) Carisoprodol;
	990	+	486
	991	+	(G) Chloral betaine;
	992	+	487
	993	+	(H) Chloral hydrate;
	994	+	488
	995	+	(I) Chlordiazepoxide;
	996	+	489
	997	+	(J) Clobazam;
	998	+	490
	999	+	(K) Clonazepam;
	1000	+	491
	1001	+	(L) Clorazepate;
	1002	+	492
	1003	+	(M) Clotiazepam;
	1004	+	493
	1005	+	(N) Cloxazolam;
	1006	+	494
	1007	+	(O) Delorazepam;
	1008	+	495
	1009	+	(P) Diazepam;
	1010	+	496
	1011	+	(Q) Dichloralphenazone;
	1012	+	497
	1013	+	(R) Estazolam;
	1014	+	498
	1015	+	(S) Ethchlorvynol;
	1016	+	499
	1017	+	(T) Ethinamate;
	1018	+	500
	1019	+	(U) Ethyl loflazepate;
	1020	+	501
	1021	+	(V) Fludiazepam;
	1022	+	502
	1023	+	(W) Flunitrazepam;
	1024	+	503
	1025	+	(X) Flurazepam;
	1026	+	504
	1027	+	(Y) Halazepam;
	1028	+	505
	1029	+	(Z) Haloxazolam;
	1030	+	506
	1031	+	(AA) Ketazolam;
	1032	+	- 15 - H.B. 500 02-13 09:46
	1033	+	507
	1034	+	(BB) Loprazolam;
	1035	+	508
	1036	+	(CC) Lorazepam;
	1037	+	509
	1038	+	(DD) Lormetazepam;
	1039	+	510
	1040	+	(EE) Mebutamate;
	1041	+	511
	1042	+	(FF) Medazepam;
	1043	+	512
	1044	+	(GG) Meprobamate;
	1045	+	513
	1046	+	(HH) Methohexital;
	1047	+	514
	1048	+	(II) Methylphenobarbital (mephobarbital);
	1049	+	515
	1050	+	(JJ) Midazolam;
	1051	+	516
	1052	+	(KK) Nimetazepam;
	1053	+	517
	1054	+	(LL) Nitrazepam;
	1055	+	518
	1056	+	(MM) Nordiazepam;
	1057	+	519
	1058	+	(NN) Oxazepam;
	1059	+	520
	1060	+	(OO) Oxazolam;
	1061	+	521
	1062	+	(PP) Paraldehyde;
	1063	+	522
	1064	+	(QQ) Pentazocine;
	1065	+	523
	1066	+	(RR) Petrichloral;
	1067	+	524
	1068	+	(SS) Phenobarbital;
	1069	+	525
	1070	+	(TT) Pinazepam;
	1071	+	526
	1072	+	(UU) Prazepam;
	1073	+	527
	1074	+	(VV) Quazepam;
	1075	+	528
	1076	+	(WW) Temazepam;
	1077	+	529
	1078	+	(XX) Tetrazepam;
	1079	+	530
	1080	+	(YY) Tramadol;
	1081	+	531
	1082	+	(ZZ) Triazolam;
	1083	+	532
	1084	+	(AAA) Zaleplon; and
	1085	+	533
	1086	+	(BBB) Zolpidem.
	1087	+	534
	1088	+	(iii) Any material, compound, mixture, or preparation of fenfluramine which contains
	1089	+	535
	1090	+	any quantity of the following substances, including its salts, isomers whether
	1091	+	536
	1092	+	optical, position, or geometric, and salts of the isomers when the existence of the
	1093	+	537
	1094	+	salts, isomers, and salts of isomers is possible.
	1095	+	538
671	1096		(iv) Unless specifically excepted or unless listed in another schedule, any material,
672		-	~~329~~
	1097	+	539
673	1098		compound, mixture, or preparation which contains any quantity of the following
674		-	330
675		-	substances having a depressant effect on the central nervous system, including its
676		-	331
677		-	salts, isomers, and salts of isomers when the existence of the salts, isomers, and
678		-	332
679		-	salts of isomers is possible within the specific chemical designation:
680		-	333
681		-	(A) Amobarbital;
682		-	334
683		-	(B) Glutethimide;
684		-	335
685		-	(C) Pentobarbital;
686		-	- 10 - 03-05 12:19 1st Sub. (Buff) H.B. 500
687		-	336
688		-	(D) Phencyclidine;
689		-	337
690		-	(E) Phencyclidine immediate precursors: 1-phenylcyclohexylamine and
691		-	338
692		-	1-piperidinocyclohexanecarbonitrile (PCC); and
693		-	339
694		-	(F) Secobarbital.
695		-	340
696		-	(v)(A) Unless specifically excepted or unless listed in another schedule, any
697		-	341
698		-	material, compound, mixture, or preparation which contains any quantity of
699		-	342
700		-	Phenylacetone.
701		-	343
702		-	(B) Some of these substances may be known by trade or other names:
703		-	344
704		-	phenyl-2-propanone; P2P; benzyl methyl ketone; and methyl benzyl ketone.
705		-	345
706		-	(vi) Nabilone, another name for nabilone: (±
707		-	346
708		-	)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,
709		-	347
710		-	6-dimethyl-9H-dibenzo[b,d]pyran-9-one.
711		-	348
712		-	(vii) A drug product or preparation that contains any component of marijuana,
713		-	349
714		-	including tetrahydrocannabinol, and is approved by the United States Food and
715		-	350
716		-	Drug Administration and scheduled by the Drug Enforcement Administration in
717		-	351
718		-	Schedule II of the federal Controlled Substances Act, Title II, P.L. 91-513.
719		-	352
720		-	(c) Schedule III:
721		-	353
722		-	(i) Unless specifically excepted or unless listed in another schedule, any material,
723		-	354
724		-	compound, mixture, or preparation which contains any quantity of the following
725		-	355
	1099	+	540
726	1100		substances having a stimulant effect on the central nervous system, including its
727		-	356
728		-	salts, isomers whether optical, position, or geometric, and salts of the isomers
729		-	357
730		-	when the existence of the salts, isomers, and salts of isomers is possible within the
731		-	358
732		-	specific chemical designation:
733		-	359
734		-	(A) Those compounds, mixtures, or preparations in dosage unit form containing
735		-	360
736		-	any stimulant substances listed in Schedule II, which compounds, mixtures, or
737		-	361
738		-	preparations were listed on August 25, 1971, as excepted compounds under
739		-	362
740		-	Section 1308.32 of Title 21 of the Code of Federal Regulations, and any other
741		-	363
742		-	drug of the quantitive composition shown in that list for those drugs or which
743		-	364
744		-	is the same except that it contains a lesser quantity of controlled substances;
745		-	365
746		-	(B) Benzphetamine;
747		-	366
748		-	(C) Chlorphentermine;
749		-	367
750		-	(D) Clortermine; and
751		-	368
752		-	(E) Phendimetrazine.
753		-	369
754		-	(ii) Unless specifically excepted or unless listed in another schedule, any material,
755		-	- 11 - 1st Sub. (Buff) H.B. 500 03-05 12:19
756		-	370
757		-	compound, mixture, or preparation which contains any quantity of the following
758		-	371
759		-	substances having a depressant effect on the central nervous system:
760		-	372
761		-	(A) Any compound, mixture, or preparation containing amobarbital, secobarbital,
762		-	373
763		-	pentobarbital, or any salt of any of them, and one or more other active
764		-	374
765		-	medicinal ingredients which are not listed in any schedule;
766		-	375
767		-	(B) Any suppository dosage form containing amobarbital, secobarbital, or
768		-	376
769		-	pentobarbital, or any salt of any of these drugs which is approved by the United
770		-	377
771		-	States Food and Drug Administration for marketing only as a suppository;
772		-	378
773		-	(C) Any substance which contains any quantity of a derivative of barbituric acid
774		-	379
775		-	or any salt of any of them;
776		-	380
777		-	(D) Chlorhexadol;
778		-	381
779		-	(E) Buprenorphine;
780		-	382
781		-	(F) Any drug product containing gamma hydroxybutyric acid, including its salts,
782		-	383
783		-	isomers, and salts of isomers, for which an application is approved under the
784		-	384
785		-	federal Food, Drug, and Cosmetic Act, Section 505;
786		-	385
787		-	(G) Ketamine, its salts, isomers, and salts of isomers, some other names for
788		-	386
789		-	ketamine: ± -2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone;
790		-	387
791		-	(H) Lysergic acid;
792		-	388
793		-	(I) Lysergic acid amide;
794		-	389
795		-	(J) Methyprylon;
796		-	390
797		-	(K) Sulfondiethylmethane;
798		-	391
799		-	(L) Sulfonethylmethane;
800		-	392
801		-	(M) Sulfonmethane; and
802		-	393
803		-	(N) Tiletamine and zolazepam or any of their salts, some trade or other names for
804		-	394
805		-	a tiletamine-zolazepam combination product: Telazol, some trade or other
806		-	395
807		-	names for tiletamine: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone, some trade
808		-	396
809		-	or other names for zolazepam:
810		-	397
811		-	4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e]
812		-	398
813		-	[1,4]-diazepin-7(1H)-one, flupyrazapon.
814		-	399
815		-	(iii) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in
816		-	400
817		-	a U.S. Food and Drug Administration approved drug product, some other names
818		-	401
819		-	for dronabinol:
820		-	402
821		-	(6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol,
822		-	403
823		-	or (-)-delta-9-(trans)-tetrahydrocannabinol.
824		-	- 12 - 03-05 12:19 1st Sub. (Buff) H.B. 500
825		-	404
826		-	(iv) Nalorphine.
827		-	405
	1101	+	- 16 - 02-13 09:46 H.B. 500
	1102	+	541
	1103	+	salts, isomers whether optical, position, or geometric isomers, and salts of the
	1104	+	542
	1105	+	isomers when the existence of the salts, isomers, and salts of isomers is possible
	1106	+	543
	1107	+	within the specific chemical designation:
	1108	+	544
	1109	+	(A) Cathine ((+)-norpseudoephedrine);
	1110	+	545
	1111	+	(B) Diethylpropion;
	1112	+	546
	1113	+	(C) Fencamfamine;
	1114	+	547
	1115	+	(D) Fenproprex;
	1116	+	548
	1117	+	(E) Mazindol;
	1118	+	549
	1119	+	(F) Mefenorex;
	1120	+	550
	1121	+	(G) Modafinil;
	1122	+	551
	1123	+	(H) Pemoline, including organometallic complexes and chelates thereof;
	1124	+	552
	1125	+	(I) Phentermine;
	1126	+	553
	1127	+	(J) Pipradrol;
	1128	+	554
	1129	+	(K) Sibutramine; and
	1130	+	555
	1131	+	(L) SPA ((-)-1-dimethylamino-1,2-diphenylethane).
	1132	+	556
828	1133		(v) Unless specifically excepted or unless listed in another schedule, any material,
829		-	406
830		-	compound, mixture, or preparation containing limited quantities of any of the
831		-	407
832		-	following narcotic drugs, or their salts calculated as the free anhydrous base or
833		-	408
834		-	alkaloid:
835		-	409
836		-	(A) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
837		-	410
838		-	milligrams per dosage unit, with an equal or greater quantity of an isoquinoline
839		-	411
840		-	alkaloid of opium;
841		-	412
842		-	(B) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
843		-	413
844		-	milligrams per dosage unit, with one or more active non-narcotic ingredients in
845		-	414
846		-	recognized therapeutic amounts;
847		-	415
848		-	(C) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not
849		-	416
850		-	more than 15 milligrams per dosage unit, with a fourfold or greater quantity of
851		-	417
852		-	an isoquinoline alkaloid of opium;
853		-	418
854		-	(D) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not
855		-	419
856		-	more than 15 milligrams per dosage unit, with one or more active, non-narcotic
857		-	420
858		-	ingredients in recognized therapeutic amounts;
859		-	421
860		-	(E) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more
861		-	422
862		-	than 90 milligrams per dosage unit, with one or more active non-narcotic
863		-	423
864		-	ingredients in recognized therapeutic amounts;
865		-	424
866		-	(F) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more
867		-	425
868		-	than 15 milligrams per dosage unit, with one or more active, non-narcotic
869		-	426
870		-	ingredients in recognized therapeutic amounts;
871		-	427
872		-	(G) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams,
873		-	428
874		-	or not more than 25 milligrams per dosage unit, with one or more active,
875		-	429
876		-	non-narcotic ingredients in recognized therapeutic amounts; and
877		-	430
878		-	(H) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams
879		-	431
880		-	with one or more active, non-narcotic ingredients in recognized therapeutic
881		-	432
882		-	amounts.
883		-	433
884		-	(vi) Unless specifically excepted or unless listed in another schedule, anabolic
885		-	434
886		-	steroids including any of the following or any isomer, ester, salt, or derivative of
887		-	435
888		-	the following that promotes muscle growth:
889		-	436
890		-	(A) Boldenone;
891		-	437
892		-	(B) Chlorotestosterone (4-chlortestosterone);
893		-	- 13 - 1st Sub. (Buff) H.B. 500 03-05 12:19
894		-	438
895		-	(C) Clostebol;
896		-	439
897		-	(D) Dehydrochlormethyltestosterone;
898		-	440
899		-	(E) Dihydrotestosterone (4-dihydrotestosterone);
900		-	441
901		-	(F) Drostanolone;
902		-	442
903		-	(G) Ethylestrenol;
904		-	443
905		-	(H) Fluoxymesterone;
906		-	444
907		-	(I) Formebulone (formebolone);
908		-	445
909		-	(J) Mesterolone;
910		-	446
911		-	(K) Methandienone;
912		-	447
913		-	(L) Methandranone;
914		-	448
915		-	(M) Methandriol;
916		-	449
917		-	(N) Methandrostenolone;
918		-	450
919		-	(O) Methenolone;
920		-	451
921		-	(P) Methyltestosterone;
922		-	452
923		-	(Q) Mibolerone;
924		-	453
925		-	(R) Nandrolone;
926		-	454
927		-	(S) Norethandrolone;
928		-	455
929		-	(T) Oxandrolone;
930		-	456
931		-	(U) Oxymesterone;
932		-	457
933		-	(V) Oxymetholone;
934		-	458
935		-	(W) Stanolone;
936		-	459
937		-	(X) Stanozolol;
938		-	460
939		-	(Y) Testolactone;
940		-	461
941		-	(Z) Testosterone; and
942		-	462
943		-	(AA) Trenbolone.
944		-	463
945		-	(vii) Anabolic steroids expressly intended for administration through implants to
946		-	464
947		-	cattle or other nonhuman species, and approved by the Secretary of Health and
948		-	465
949		-	Human Services for use, may not be classified as a controlled substance.
950		-	466
951		-	(viii) A drug product or preparation that contains any component of marijuana,
952		-	467
953		-	including tetrahydrocannabinol, and is approved by the United States Food and
954		-	468
955		-	Drug Administration and scheduled by the Drug Enforcement Administration in
956		-	469
957		-	Schedule III of the federal Controlled Substances Act, Title II, P.L. 91-513.
958		-	470
959		-	(ix) Nabiximols.
960		-	471
961		-	(x) Amanita Muscaria.
962		-	- 14 - 03-05 12:19 1st Sub. (Buff) H.B. 500
963		-	472
964		-	(d) Schedule IV:
965		-	473
966		-	(i) Unless specifically excepted or unless listed in another schedule, any material,
967		-	474
968		-	compound, mixture, or preparation containing not more than 1 milligram of
969		-	475
970		-	difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit, or
971		-	476
972		-	any salts of any of them.
973		-	477
974		-	(ii) Unless specifically excepted or unless listed in another schedule, any material,
975		-	478
976		-	compound, mixture, or preparation which contains any quantity of the following
977		-	479
978		-	substances, including its salts, isomers, and salts of isomers when the existence of
979		-	480
980		-	the salts, isomers, and salts of isomers is possible within the specific chemical
981		-	481
982		-	designation:
983		-	482
984		-	(A) Alprazolam;
985		-	483
986		-	(B) Barbital;
987		-	484
988		-	(C) Bromazepam;
989		-	485
990		-	(D) Butorphanol;
991		-	486
992		-	(E) Camazepam;
993		-	487
994		-	(F) Carisoprodol;
995		-	488
996		-	(G) Chloral betaine;
997		-	489
998		-	(H) Chloral hydrate;
999		-	490
1000		-	(I) Chlordiazepoxide;
1001		-	491
1002		-	(J) Clobazam;
1003		-	492
1004		-	(K) Clonazepam;
1005		-	493
1006		-	(L) Clorazepate;
1007		-	494
1008		-	(M) Clotiazepam;
1009		-	495
1010		-	(N) Cloxazolam;
1011		-	496
1012		-	(O) Delorazepam;
1013		-	497
1014		-	(P) Diazepam;
1015		-	498
1016		-	(Q) Dichloralphenazone;
1017		-	499
1018		-	(R) Estazolam;
1019		-	500
1020		-	(S) Ethchlorvynol;
1021		-	501
1022		-	(T) Ethinamate;
1023		-	502
1024		-	(U) Ethyl loflazepate;
1025		-	503
1026		-	(V) Fludiazepam;
1027		-	504
1028		-	(W) Flunitrazepam;
1029		-	505
1030		-	(X) Flurazepam;
1031		-	- 15 - 1st Sub. (Buff) H.B. 500 03-05 12:19
1032		-	506
1033		-	(Y) Halazepam;
1034		-	507
1035		-	(Z) Haloxazolam;
1036		-	508
1037		-	(AA) Ketazolam;
1038		-	509
1039		-	(BB) Loprazolam;
1040		-	510
1041		-	(CC) Lorazepam;
1042		-	511
1043		-	(DD) Lormetazepam;
1044		-	512
1045		-	(EE) Mebutamate;
1046		-	513
1047		-	(FF) Medazepam;
1048		-	514
1049		-	(GG) Meprobamate;
1050		-	515
1051		-	(HH) Methohexital;
1052		-	516
1053		-	(II) Methylphenobarbital (mephobarbital);
1054		-	517
1055		-	(JJ) Midazolam;
1056		-	518
1057		-	(KK) Nimetazepam;
1058		-	519
1059		-	(LL) Nitrazepam;
1060		-	520
1061		-	(MM) Nordiazepam;
1062		-	521
1063		-	(NN) Oxazepam;
1064		-	522
1065		-	(OO) Oxazolam;
1066		-	523
1067		-	(PP) Paraldehyde;
1068		-	524
1069		-	(QQ) Pentazocine;
1070		-	525
1071		-	(RR) Petrichloral;
1072		-	526
1073		-	(SS) Phenobarbital;
1074		-	527
1075		-	(TT) Pinazepam;
1076		-	528
1077		-	(UU) Prazepam;
1078		-	529
1079		-	(VV) Quazepam;
1080		-	530
1081		-	(WW) Temazepam;
1082		-	531
1083		-	(XX) Tetrazepam;
1084		-	532
1085		-	(YY) Tramadol;
1086		-	533
1087		-	(ZZ) Triazolam;
1088		-	534
1089		-	(AAA) Zaleplon; and
1090		-	535
1091		-	(BBB) Zolpidem.
1092		-	536
1093		-	(iii) Any material, compound, mixture, or preparation of fenfluramine which contains
1094		-	537
1095		-	any quantity of the following substances, including its salts, isomers whether
1096		-	538
1097		-	optical, position, or geometric, and salts of the isomers when the existence of the
1098		-	539
1099		-	salts, isomers, and salts of isomers is possible.
1100		-	- 16 - 03-05 12:19 1st Sub. (Buff) H.B. 500
1101		-	540
1102		-	(iv) Unless specifically excepted or unless listed in another schedule, any material,
1103		-	541
1104		-	compound, mixture, or preparation which contains any quantity of the following
1105		-	542
1106		-	substances having a stimulant effect on the central nervous system, including its
1107		-	543
1108		-	salts, isomers whether optical, position, or geometric isomers, and salts of the
1109		-	544
1110		-	isomers when the existence of the salts, isomers, and salts of isomers is possible
1111		-	545
1112		-	within the specific chemical designation:
1113		-	546
1114		-	(A) Cathine ((+)-norpseudoephedrine);
1115		-	547
1116		-	(B) Diethylpropion;
1117		-	548
1118		-	(C) Fencamfamine;
1119		-	549
1120		-	(D) Fenproprex;
1121		-	550
1122		-	(E) Mazindol;
1123		-	551
1124		-	(F) Mefenorex;
1125		-	552
1126		-	(G) Modafinil;
1127		-	553
1128		-	(H) Pemoline, including organometallic complexes and chelates thereof;
1129		-	554
1130		-	(I) Phentermine;
1131		-	555
1132		-	(J) Pipradrol;
1133		-	556
1134		-	(K) Sibutramine; and
1135	1134		557
1136		-	~~(L) SPA ((-)-1-dimethylamino-1,2-diphenylethane).~~
	1135	+	compound, mixture, or preparation which contains any quantity of
1137	1136		558
1138		-	(v) ~~Unless specifically excepted or unless listed in another schedule~~, ~~any material,~~
	1137	+	dextropropoxyphene (alpha-(+)-4-dimethylamino-1,
1139	1138		559
1140		-	~~compound~~, ~~mixture, or preparation which contains any quantity of~~
	1139	+	2-diphenyl-3-methyl-2-propionoxybutane), including its salts.
1141	1140		560
1142		-	~~dextropropoxyphene (alpha-(+)-4-dimethylamino-1,~~
	1141	+	(vi) A drug product or preparation that contains any component of marijuana and is
1143	1142		561
1144		-	~~2-diphenyl-3-methyl-2-propionoxybutane), including its salts.~~
	1143	+	approved by the United States Food and Drug Administration and scheduled by
1145	1144		562
1146		-	~~(vi) A~~ drug ~~product or preparation that contains any component~~ of ~~marijuana and is~~
	1145	+	the Drug Enforcement Administration in Schedule IV of the federal Controlled
1147	1146		563
1148		-	~~approved by the United States Food and Drug Administration and scheduled by~~
	1147	+	Substances Act, Title II, P.L. 91-513.
1149	1148		564
1150		-	~~the Drug Enforcement Administration in~~ Schedule ~~IV of the federal Controlled~~
	1149	+	(e) Schedule V:
1151	1150		565
1152		-	~~Substances Act~~, ~~Title II~~, ~~P.L. 91-513.~~
	1151	+	(i) Any compound, mixture, or preparation containing any of the following limited
1153	1152		566
1154		-	~~(e) Schedule V:~~
	1153	+	quantities of narcotic drugs, or their salts calculated as the free anhydrous base or
1155	1154		567
1156		-	~~(i) Any compound~~, ~~mixture,~~ or ~~preparation containing any of the following limited~~
	1155	+	alkaloid, which includes one or more non-narcotic active medicinal ingredients in
1157	1156		568
1158		-	~~quantities of narcotic drugs~~, or ~~their salts calculated as the free anhydrous base or~~
	1157	+	sufficient proportion to confer upon the compound, mixture, or preparation
1159	1158		569
1160		-	~~alkaloid, which includes one or more non-narcotic active~~ medicinal ~~ingredients in~~
	1159	+	valuable medicinal qualities other than those possessed by the narcotic drug alone:
1161	1160		570
1162		-	~~sufficient proportion to confer upon the compound,~~ ~~mixture,~~ or ~~preparation~~
	1161	+	(A) not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;
1163	1162		571
1164		-	~~valuable medicinal qualities other~~ than ~~those possessed by the narcotic drug alone:~~
	1163	+	(B) not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100
1165	1164		572
1166		-	~~(A) not more than 200 milligrams of codeine per 100 milliliters or per 100~~ grams;
	1165	+	grams;
1167	1166		573
1168		-	(B) not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100
1169		-	- 17 - 1st Sub. (Buff) H.B. 500 03-05 12:19
	1167	+	(C) not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100
1170	1168		574
1171	1169		grams;
	1170	+	- 17 - H.B. 500 02-13 09:46
1172	1171		575
1173		-	(C) not more than ~~100~~ milligrams of ~~ethylmorphine per 100 milliliters or per 100~~
	1172	+	(D) not more than 2.5 milligrams of diphenoxylate and not less than 25
1174	1173		576
1175		-	~~grams~~;
	1174	+	micrograms of atropine sulfate per dosage unit;
1176	1175		577
1177		-	(D) not more than ~~2.5~~ milligrams of ~~diphenoxylate and not less than 25~~
	1176	+	(E) not more than 100 milligrams of opium per 100 milliliters or per 100 grams;
1178	1177		578
1179		-	micrograms of ~~atropine sulfate per dosage unit;~~
	1178	+	(F) not more than 0.5 milligram of difenoxin and not less than 25 micrograms of
1180	1179		579
1181		-	~~(E) not more than 100 milligrams of opium~~ per ~~100 milliliters or per 100 grams;~~
	1180	+	atropine sulfate per dosage unit; and
1182	1181		580
1183		-	(F) ~~not more than 0.5 milligram of difenoxin and not less than 25 micrograms of~~
	1182	+	(G) unless specifically exempted or excluded or unless listed in another schedule,
1184	1183		581
1185		-	~~atropine sulfate per dosage unit;~~ ~~and~~
	1184	+	any material, compound, mixture, or preparation which contains Pyrovalerone
1186	1185		582
1187		-	~~(G) unless specifically exempted or excluded or unless listed in another schedule~~,
	1186	+	having a stimulant effect on the central nervous system, including its salts,
1188	1187		583
1189		-	~~any material~~, ~~compound, mixture,~~ ~~or preparation which contains Pyrovalerone~~
	1188	+	isomers, and salts of isomers.
1190	1189		584
1191		-	~~having~~ a ~~stimulant effect on the central nervous system~~, ~~including its salts,~~
	1190	+	(ii) A drug product or preparation that contains any component of marijuana,
1192	1191		585
1193		-	~~isomers~~, and ~~salts of isomers.~~
	1192	+	including cannabidiol, and is approved by the United States Food and Drug
1194	1193		586
1195		-	~~(ii) A~~ drug ~~product or preparation that contains any component of marijuana,~~
	1194	+	Administration and scheduled by the Drug Enforcement Administration in
1196	1195		587
1197		-	~~including cannabidiol,~~ ~~and is approved by~~ the ~~United States Food and Drug~~
	1196	+	Schedule V of the federal Controlled Substances Act, Title II, P.L. 91-513.
1198	1197		588
1199		-	~~Administration and scheduled by the Drug Enforcement Administration in~~
	1198	+	(iii) Gabapentin.
1200	1199		589
1201		-	~~Schedule V of the federal Controlled Substances Act, Title II, P.L~~. ~~91-513~~.
	1200	+	Section 2. Effective Date.
1202	1201		590
1203		-	(iii) Gabapentin.
1204		-	591
1205		-	(3) If the federal government schedules the pharmaceutical composition of
1206		-	592
1207		-	crystallinepolymorph psilocybin in a schedule that is not schedule I, that composition is
1208		-	593
1209		-	deemed scheduled under this section in the same schedule that the composition is
1210		-	594
1211		-	scheduled under 21 U.S.C. Sec. 812 and 21 C.F.R. Sec. 1308.14.
1212		-	595
1213		-	Section 2. Effective Date.
1214		-	596
1215	1202		This bill takes effect on May 7, 2025.
1216	1203		- 18 -